Provided by Tiger Trade Technology Pte. Ltd.

Incyte

117.14
-4.2100-3.47%
Post-market: 116.50-0.6400-0.55%19:30 EDT
Volume:2.36M
Turnover:279.69M
Market Cap:23.74B
PE:14.92
High:121.22
Open:120.47
Low:117.00
Close:121.35
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:1.60
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.74
PE(LYR):18.27

Loading ...

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

TIPRANKS
·
Sep 01

Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing

THOMSON REUTERS
·
Sep 01

Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing

THOMSON REUTERS
·
Sep 01

Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing

THOMSON REUTERS
·
Sep 01

Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing

THOMSON REUTERS
·
Sep 01

Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz

Simply Wall St.
·
Aug 30

US FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer

Reuters
·
Aug 29

Incyte Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Incyte Corp Drops in Volume Surge, Last Down 3.0%

THOMSON REUTERS
·
Aug 29

Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil

MT Newswires Live
·
Aug 28

Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 26

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts

TIPRANKS
·
Aug 22

Incyte President, Global Head of R&D Pablo J. Cagnoni Sells 10,801 Shares for $1.36 Million

Reuters
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Incyte : Canaccord Genuity Initiates Coverage with Buy Rating; Price Target $152

THOMSON REUTERS
·
Aug 20

Incyte Price Target Maintained with a $150.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 20

Canaccord Genuity Initiates Incyte at Buy With $152 Price Target

MT Newswires Live
·
Aug 20

Incyte Corp. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 20

Matt Phipps Maintains Hold Rating on Incyte as Promising Early KRAS G12D PDAC Data Face Durability and Safety Uncertainties

TIPRANKS
·
Aug 20